Non-Hodgkin's lymphomas (NHL) are considered to represent monoclonal proliferations of single lymphoid cells (Levy et al., 1977) . Recently it has been shown that more than one clone can be present as determined by DNA analysis and surface immunoglobulin (slg) (Sklar et al., 1984) . In the great majority of cases in adults, the malignant population is derived from the B cell line and thus bear Ig on the cell surface or intracellularly (Aisenberg & Long, 1975; Lukes et al., 1978) . The Ig produced by the cells of one B cell clone comprises the same light chain, either kappa (K) or, lambda (A). The normal ratio of K and A bearing lymphocytes in man is 2: 1 (Grey et al., 1971; Garrett et al., 1979) , and a shift in the ratio indicates the presence of a monoclonal B cell population. Furthermore, the amount of sIg per cell in a monoclonal population is rather homogeneous, compared with that of a normal, polyclonal B cell population which is very heterogeneous (Killander et al., 1977; Slease et al., 1979) . In a quantitative analysis of the light chain distribution in a lymphocyte population, the monoclonal cells will appear as a peak in the fluorescence profile of either K or A labelled cells. In patients with NHL of B cell type, a disturbed K/I distribution thus indicates spread of lymphoma cells into the circulation (Ault, 1979; Ligler et al., 1979 Ligler et al., , 1980 The aim of the present study was to assess the capacity of quantitative immunofluorometry of slg light chains for the detection of circulating lymphoma cells and to compare these findings with standard haematological methods (blood microscopy or peripheral white blood cell count). The results are also correlated with tumour burden to estimate the usefulness of K/2 distribution analysis in staging, treatment monitoring and in follow up of lymphoma patients.
Materials and methods

Patients
The subjects studied were 96 patients with different kinds of NHL, investigated, treated and followed at the University Hospital of Lund, Sweden. In addition, 17 patients with various benign and other malignant diseases were studied.
In all cases diagnosis was based on a surgical biopsy and the lymphomas were classified according to the Kiel classification. In 19 patients immunological typing of the lymphoma was performed using flow cytometric quantitation of slg in viable cell suspensions. B cell origin was confirmed in 18 by light chain restriction. The distribution of patients according to histopathological category is shown in Table I . The low grade malignant group includes malignant lymphoma (ml) lymphocytic (lc), immunocytic (ic), centrocytic (cc) and centroblastic/centrocytic (cb cc). The high grade malignant group includes ml centroblastic (cb). immunoblastic (ib) and lymphoblastic (lb).
In 22 patients the analysis was performed in primary staging which also included physical examination, chest X-ray, biopsies from Waldeyer's nng, percutaneous fine needle biopsy and scintigraphy of the liver and spleen, CT scan of the abdomen and pelvis, bone marrow biopsy and aspiration, routine haematology and blood microscopy. Staging laparotomy was not performed.
In 74 patients the immunological analysis was performed during treatment or in follow up. In these patients a peripheral white blood cell count (wbcc) was done routinely at every check up. A differential count was performed only if the wbcc was above the normal range (>10x1091 -1). The blood microscopy was performed at the routine laboratory. (Lobo et al., 1975; Kumagai et al., 1975) . They were then washed once and resuspended in Dulbecco buffer solution containing 1% BSA and 0.1% NaN3. FITC-conjugated F(ab')2 fragments of goat anti human K and burro anti human i. and a polyvalent goat anti human Ig (Kallestad Laboratories Inc.) were used at appropriate dilutions to ensure saturating conditions. Cells (4 x 105) were incubated with antiserum for 30min at room temperature and then washed 3 times. The fluorescence analysis was performed within 24h.
Flow cytometric analysis
The fluorescence analysis was done on single cell suspensions using a flow cytometer (Ortho Cytofluorograph System 50-H) with two simultaneous laser beams. Cell size was measured in axial light extinction using a Helium-Neon laser at 632,8 nm (0.8mW). Fluorescence excitation was performed by an Argon-ion laser at 488 nm (200 mW), and measured in a green filter combination (515-555 nm). The sample was first studied in a cytogram in a dual presentation of axial light extinction and green fluorescence. The lymphocyte population was selected to avoid disturbing fluorescence from monocytes, dead cells and debris. In the selected population the fluorescence intensity per cell was displayed in a frequency distnrbution using 511 linear channels of increasing fluorescence on the horizontaTl axis and the number of individual cells within each channel on the vertical axis. Ten thousand cells were measured in each analysis. The frequency distributions of the amount of K and i. per cell in the population were visually compared by superimposing the two fluorescence profiles in a double exposed picture (K/i. distribution). If there was a distinct incongruity between the two-distributions, the sample was considered to be abnormal. The control (healthy blood donors) was analysed to show the normal identity of K and i. fluorescence profiles (Figure 1 ). The channel number defining fluorescence positivity was estimated from the control, and remained almost invariably constant from day to day with the same gain settings. The percentage of K and i. positive cells and the ratio were calculated. A K:. ratio outside the range 0.5-4 was considered abnormal (Garrett et al., 1979) . showed normal K/2 profiles: One with ml cb/cc, one with ml lc and one with ml ib. The patient with ml cb/cc (no. 13) had lymphoma cells in the bone marrow, a wbcc of 14.7 x 1091-1, a normal lymphocyte count, 3.3 x 1091-1 but his lymphocytes were described as abnormal. The patient with ml lc had had a classical chronic lymphocytic leukaemia (B-CLL) for several years. Treatment had been started recently with Prednimustine. His lymphocyte count was 104 x 1091-1. Although quantitative light chain analysis showed virtually no detectable amounts of K or A, using a polyvalent anti-human Ig all cells stained faintly, but were clearly abnormal, confirming B cell origin (Grey et al., 1971; Preud'Homme & Seligmann, 1972) . The patient with ml lb was extensively diseased with enlarged lymph nodes, bone marrow, skin and CNS involvement. He was on intensive chemotherapy and steroid treatment. His wbcc was 22x1091-1 with 1.3 x 109 lymphocytes l-'. An abundant population of very large, atypical mononuclear cells were negative for slg. He died shortly hereafter. His lymphoma was not immunologically typed.
K/2 distribution compared with K:) ratio (Table I) In 20 patients with abnormal KIA distributions but normal peripheral blood according to standard morphological methods, the K:) ratio was abnormal in 10-all in patients with active disease. K/I ratios were normal in 3 patients with clinically overt leukaemia and abnormal K/2 profiles. Two of these were diagnosed as lymphocytic lymphomas/CLL and the quantitative light (Table II) Five patients presented with localized disease, stage I-H. In one of these (no. 10) the K/A distribution in the peripheral blood was abnormal despite a normal K: A ratio.
Seventeen patients presented with advanced disease (stage IV). Only 4 of these were nonleukaemic according to standard methods. In one of these the K/A distribution analysis was abnormal, despite a normal K:A ratio (no. 18).
Of the patients with leukaemic lymphomas, 12 were identified in the K/A distribution analysis and 11 by K:A ratio. The patient not revealed in the immunological analyses (no. 13) has been discussed above.
K/A distribution in patients in CR (Tables   and   IV) Thirty eight patients were in CR for a median 10 months (0-95) when the immunological analysis was performed. In the group with abnormal K/2 distributions 2/7 relapsed (1 low grade ml, 1 high grade ml) compared with 7/31 in the CR group with normal K/A distributions (5 low grade ml, 2 high grade ml).
K/2 distribution in patients with active disease (Tables III and IV) This group included 22 patients analysed in primary staging and 36 patients examined at variable times after diagnosis. In 20 patients treatment with chemotherapy was ongoing.
In patients with active disease 33/58 (57%) showed abnormal K/2 patterns in the peripheral blood. Looking only at those with normal routine, haematology the corresponding figures were 13/35 (37%). All but 2 were in the low grade malignant group. Eight of these 13 patients also showed abnormal K:i ratios.
In patients with a large tumour burden 26/43 (60%) showed abnormal K/2 distributions. The corresponding figure in the group with minimal disease was 7/15 (47%). In patients with normal routine haematology but abnormal K/2 distribution the figures were 6/20 (30%) in the group with a large tumour burden and 7/15 (47%) in the group with minimal disease. These differences were not significant (Chi-square test, Fischer's exact test).
Discussion
In patients with NHL of B cell type, a disturbed K:2A ratio, or more precisely, an abnormal K/2 distribution in the lymphocyte population in the peripheral blood, is a strong indication of circulating lymphoma cells. This is not, however, absolute proof, since light chain restriction in a population is merely evidence of monoclonal cells (Teodorescu et al., 1978; Ault, 1979) . Although identification of the idiotype would be the true clonal marker, this is a tedious procedure, inconvenient for routine examination.
In this study immunological classification of the lymphoma was performed in 19/96 patients. In all of these cases with a pathological K/2 distribution, the identified light chain was identical in blood and lymphoma tissue (10/19). None of the 17 patients with various other malignant or benign diseases showed abnormal K/2 patterns in their peripheral blood. Thus, even if the possibility that some other disorder might cause an immunological disturbance resulting in a shift in the K/A distribution cannot be ruled out, it does seem more likely that this finding, in a patient with a B cell malignancy, indicates dissemination of lymphoma cells Another possible source of error might be the presence of monoclonal Ig in the serum of the patients. Theoretically such Ig could be passively adsorbed to the normal lymphocytes, thus simulating a monoclonal population. This does not seem to be a major drawback, when using the preincubation procedures described by Lobo et al. (1975) (Ault, 1979; Ligler et al., 1979 ). An abnormal K/IA distribution on peripheral blood lymphocytes was a more common finding in patients with low grade malignant lymphomas Almost two-thirds of these patients showed immunological evidence of circulating lymphoma cells. Similar results have been reported by others (Abdul-Cader et al., 1983) and are consitent with the fnding that these indolent lymphomas are widely diinated (Heifetz et al., 1980) . We had anticpated finding a correlation between tumour mas and presence of circulating lymphoma cells Even if the proportion of patients with abnormal K/A patterns tended to be higher in the group with a large tumour burden compared to those with minimal disease, the difference was not significant Evidently, the presence of malignant cells in the peripheral blood was related more to tumour type than tumour burden.
It is known that determination of K-.i ratios is superior to conventional haematology for the detection of leukaemic spread in B cell lymphomas (Garrett et al., 1979) . We have compared the sensitivity of K:A ratio determinations with those of K/IA distributions. Since K/2 distribution analysis is in essence a light chain estimation at discrete levels of fluorescence, it would be logical to assume that the distribution analysis is more sensitive (Ligler et al, 1980) . When only small numbers of monoclonal cells are present, neither the total percentage nor the ratio of K and A positive cells will be much changed. Moreover, the normal range of the ratio is broad, which futher reduces sensitivity. Our data support these ideas, since we found the K/A distribution analysis to be a clearly more sensitive method.
The finding of an abnormal K/A distribution in 18% (7/38) of the patients considered to be in CR for, in some cases, several years, is of great interest.
The majority of them (6/7) had low grade malignant lymphomas. These results might be compatible with the current opinion that these lymphomas are chronic diseases with a constant relape rate over many years (McKelvey & Moon, 1977) . In 17 months (median) follow up only one of these 6 patients has relapsed. The only patient with a high grade malignant lymphoma in CR and with abnormal K/A distribution relapsed shortly thereafter. In the CR group without any signs of circulating lymphoma cells in the immunological analysis the relapse rate was much the same 22% (7/31). More patients and a longer period of follow up is needed before any conclusions can be drawn.
In patients with active disease and normal routine haematology the K/A distribution analysis yielde a diagnostic gain in 37%. We failed to identify three leukaemic samples by K/i distribution analysis The first was a patient with ml cb/cc with marrow involvement but a normal blood lymphocyte count One possible explanation might be that the cells described as abnormal in the blood smear were actually activated normal lymphocytes rather than lymphoma cells. The second patient had a CLL of B cell type, as determined by the analysis of the total amount of slg. The amount of light chain was, however, below the detectable leveL thus yielding a negative findig in the K/A profile (Ligler et al., 1983) . In the third paient, with ml ib it might be that the lymphoma was not of B cell linee, sine it is known that this group also includes T cell tumours (Habeshaw et al., 1983) .
The centrocytic lymphomas comprise a small group, not permitting too extensive condusions. Nonetheless, it is our definite impression, that it is in this group that we find the most striking differences between routine haematology and K/iA distnrbution analyses. This might reflect an inherent feature in the behaviour of this tumour (Swerdlow et al., 1983) or might be due to methodological aspects. In our experience, centrocytes have a high
Ig density on the cell surface and are easily detected by immunological analysis, although they might be difficult to distinguish as malignant in a routine blood smear. The conclusion to be drawn from this study is that quantitative light chain analysis is a more sensitive method of detecting circulating lymphoma cells than routine haematological methods. It is a simple and convenient test well suited for routine use in monitoring patients with NHL during treatment and in follow up. The prognostic significance of small numbers of circulating lymphoma cells in patients in CR and in stage I disease has yet to be ascertained. Further studies and long term follow up is needed.
